Category Archives: J. CONDITIONS TO TREAT

A new tool to test the biological effects of biofeedback, meditation, and yoga

OK. Stay with me on this.

Kevin Tracey, MD is director and CEO of The Feinstein Institute for Medical Research in New York. A well-respected researcher, Dr. Tracey discovered that the brain controls the immune system via the vagus nerve. Now he’s investigating the role of a molecule called tumor necrosis factor (TNF) as part of the immune system’s weapons against foreign invaders. TNF can cause pain and redness to an injury or infection. In excessive amounts, it can also cause shock and death.

What’s this got to do with CAM?

Maybe a lot.

Continue reading A new tool to test the biological effects of biofeedback, meditation, and yoga →

More thoughts on the role of selenium in preventing diabetes

A recently published study concluded, “Selenium supplementation does not seem to prevent type 2 diabetes, and it may increase risk for the disease.”

The study was summarized here. Now, an article on HealthNotesNewswire by Dr. Allan Gaby, a specialist in nutrition and preventive medicine, lists criticisms of the research. Dr. Gaby’s article is instructive because in addition to the relevance of the criticisms to the selenium study, it provides a checklist of basic questions to ask when reading any retrospective review. Continue reading More thoughts on the role of selenium in preventing diabetes →

Ayurvedic lead poisoning results in greater toxicity than lead paint intoxication

Researchers from Harvard School of Public Health in Boston believe, “the United States Food and Drug Administration and corresponding agencies in other countries should require heavy metal testing for all imported dietary supplements.”

The recommendation is based on what they found among people taking Ayurvedic medicines. Continue reading Ayurvedic lead poisoning results in greater toxicity than lead paint intoxication →

Should cognitive behavioral therapy be added to antidepressant therapy?

A study in the British Medical Journal concludes that adding weekly cognitive behavioral therapy (CBT) to treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac) was no more beneficial for depressed adolescents than medication alone.

A closer look suggests the Adolescent Depression Antidepressant and Psychotherapy Trial (ADAPT) is not the definitive study on this subject.

Here’s why. Continue reading Should cognitive behavioral therapy be added to antidepressant therapy? →

Anael, his tumors, and the Hippocrates Health Institute

Anael L’Esperance-Nascimento (photo) is the little boy from Quebec whose parents refused a second round of chemotherapy for his brain and spinal cord tumors. Instead, Anael will be treated at the Hippocrates Health Institute in Florida.

The intent of this post is to review wheatgrass, “an integral part” of the Hippocrates treatment. Continue reading Anael, his tumors, and the Hippocrates Health Institute →

Experts respond to the negative AHRQ report on meditation

The report by the University of Alberta Evidence-based Practice Center (UAEPC) after reviewing the published literature on meditation practices for health were published here and discussed here.

The authors found so many flaws in the design of the studies that “conclusions on the effects of meditation practices in healthcare cannot be drawn based on the available evidence.” The report was funded by the NIH Agency for Healthcare Research and Quality (AHRQ). Continue reading Experts respond to the negative AHRQ report on meditation →

Insufficient proof of efficacy for marijuana spray to permit sale in the UK

GW Pharmaceuticals was able to prove that Sativex, their marijuana oral spray product, was safe and reliably contained sufficient tetrahydrocannabinol. But proof of effectiveness was lacking, in the view of the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) Continue reading Insufficient proof of efficacy for marijuana spray to permit sale in the UK →